PL361630A1 - Środki lecznicze zawierające enzymy z orzęsków, wspomagające trawienie - Google Patents

Środki lecznicze zawierające enzymy z orzęsków, wspomagające trawienie

Info

Publication number
PL361630A1
PL361630A1 PL01361630A PL36163001A PL361630A1 PL 361630 A1 PL361630 A1 PL 361630A1 PL 01361630 A PL01361630 A PL 01361630A PL 36163001 A PL36163001 A PL 36163001A PL 361630 A1 PL361630 A1 PL 361630A1
Authority
PL
Poland
Prior art keywords
ciliates
medicaments
promoting digestion
enzymes obtained
enzymes
Prior art date
Application number
PL01361630A
Other languages
English (en)
Other versions
PL204599B1 (pl
Inventor
Marcus Hartmann
Original Assignee
Cilian Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilian Ag filed Critical Cilian Ag
Publication of PL361630A1 publication Critical patent/PL361630A1/pl
Publication of PL204599B1 publication Critical patent/PL204599B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
PL361630A 2000-11-02 2001-11-02 Enzymy uzyskane z orzęsków i ich zastosowanie PL204599B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054239 2000-11-02
PCT/EP2001/012740 WO2002036156A1 (de) 2000-11-02 2001-11-02 Verwendung von aus ciliaten gewonnenen enzymen als verdauungsfördernde arzneimittel

Publications (2)

Publication Number Publication Date
PL361630A1 true PL361630A1 (pl) 2004-10-04
PL204599B1 PL204599B1 (pl) 2010-01-29

Family

ID=7661849

Family Applications (1)

Application Number Title Priority Date Filing Date
PL361630A PL204599B1 (pl) 2000-11-02 2001-11-02 Enzymy uzyskane z orzęsków i ich zastosowanie

Country Status (16)

Country Link
US (2) US20040033220A1 (pl)
EP (1) EP1330262B1 (pl)
JP (1) JP4139215B2 (pl)
CN (1) CN1262308C (pl)
AT (1) ATE295737T1 (pl)
AU (2) AU2366602A (pl)
CA (1) CA2427537A1 (pl)
DE (1) DE50106273D1 (pl)
DK (1) DK1330262T3 (pl)
ES (1) ES2239686T3 (pl)
IL (2) IL155515A0 (pl)
NO (1) NO20031979L (pl)
PL (1) PL204599B1 (pl)
PT (1) PT1330262E (pl)
RU (1) RU2299074C2 (pl)
WO (1) WO2002036156A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060127857A (ko) * 2003-10-29 2006-12-13 알투스 파마슈티컬스 인코포레이티드 혈장 콜레시스토키닌(ｃｃｋ) 농도 조절 및 통증 치료를위한 비-췌장 프로테아제
CA2560613C (en) * 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
WO2005098427A2 (en) * 2004-04-05 2005-10-20 Arbab Saccharides Science & Technology Co. Ltd Method, composition and device for treating starch related diseases
WO2005099748A1 (de) * 2004-04-13 2005-10-27 Cilian Ag Rekombinante lysosomale enzyme mit ciliaten-typischem glykosylierungsmuster für die therapie
HUE031042T2 (en) * 2005-07-29 2017-06-28 Abbott Laboratories Gmbh Methods for producing pancreatin powder with low viral content
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
RU2385158C2 (ru) * 2007-07-03 2010-03-27 Государственное научное учреждение Всероссийский научно-исследовательский институт мясной промышленности им. В.М. Горбатова Российской академии сельскохозяйственных наук Средство для лечения диареи у поросят "колимак", способ его получения и способ лечения диареи у поросят
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2328566A1 (en) * 2008-09-30 2011-06-08 DSM IP Assets B.V. Enzyme composition and application thereof in the treatment of pancreatic insufficiency
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
CN115803083A (zh) * 2020-06-24 2023-03-14 基利安股份公司 新脂肪酶
US20240191275A1 (en) * 2021-04-09 2024-06-13 Cilian Ag Purification of proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454566B (sv) * 1984-04-24 1988-05-16 Lars G I Hellgren Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
CA2110497C (en) * 1991-07-01 2005-04-19 Reinhard Braatz Use of bacterial lipases for producing drugs for maldigestion therapy
DE4238842A1 (de) * 1992-11-17 1994-05-19 Arno Prof Dr Tiedtke Hochzelldichte Fermentation von Ciliaten zur Gewinnung von Naturstoffen
DE19524307A1 (de) * 1995-07-07 1997-01-09 Hoechst Ag Verfahren zur Massenkultivierung von Ciliaten
DE19724845A1 (de) * 1996-08-28 1998-03-05 Solvay Pharm Gmbh Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
US6846481B1 (en) * 1999-02-04 2005-01-25 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
US6539128B1 (en) * 1999-04-16 2003-03-25 Macronix International Co., Ltd. Method and apparatus for interpolation
US6543100B1 (en) * 2001-09-24 2003-04-08 Christopher J. Finley Test tube retention system

Also Published As

Publication number Publication date
EP1330262B1 (de) 2005-05-18
HK1057861A1 (en) 2004-04-23
DK1330262T3 (da) 2005-09-19
WO2002036156A1 (de) 2002-05-10
JP4139215B2 (ja) 2008-08-27
IL155515A (en) 2009-02-11
DE50106273D1 (de) 2005-06-23
AU2002223666B2 (en) 2006-08-24
NO20031979D0 (no) 2003-04-30
RU2299074C2 (ru) 2007-05-20
CN1262308C (zh) 2006-07-05
ATE295737T1 (de) 2005-06-15
ES2239686T3 (es) 2005-10-01
AU2366602A (en) 2002-05-15
PT1330262E (pt) 2005-07-29
PL204599B1 (pl) 2010-01-29
US20080292610A1 (en) 2008-11-27
EP1330262A1 (de) 2003-07-30
IL155515A0 (en) 2003-11-23
JP2004512375A (ja) 2004-04-22
CA2427537A1 (en) 2002-05-10
NO20031979L (no) 2003-06-30
US20040033220A1 (en) 2004-02-19
CN1484530A (zh) 2004-03-24

Similar Documents

Publication Publication Date Title
IL155515A0 (en) Use of enzymes obtained from ciliates as medicaments for promoting digestion
MXPA03007527A (es) Enzimas que tienen actividad de alfa amilasa y metodos de uso de las mismas.
EP1463512A4 (en) USE OF P97 AS AN ENZYME DELIVERY SYSTEM FOR THE DELIVERY OF THERAPEUTIC LYSOSOMAL ENZYMES
MXPA02002901A (es) Enzimas de ruta de enfocado lisosomal.
HUP0500560A2 (hu) Mikróbás enzimek új keverékei
DK1162995T3 (da) Enzymer til behandling af diabetes mellitus type I
IL151313A0 (en) Lipase containing pharmaceutical compositions
DK1755656T3 (da) Enzymer til farmaceutisk anvendelse
AP1697A (en) Azabicycloalkanes as CCR5 modulators.
NZ502519A (en) Enzymes mixture containing xylanases, beta-glucanases and ferulolyl esterases
WO1999043651A3 (en) Inhibitors of phospholipase enzymes
AU4056700A (en) Phosphatases with improved phytase activity
NO953312D0 (no) Alkalitolerante xylanaser
AU2002223666A1 (en) Use of enzymes obtained from ciliates as medicaments for promoting digestion
WO2003099202A3 (en) Beta-secretase inhibitors
AU3214100A (en) Liquid descaling composition
GB0011060D0 (en) Improvements relating to gene directed enzyme prodrug therapy
WO2001066709A3 (en) Sphingomyelinase enzymes and uses relating thereto
MXPA03008984A (es) D-hidantoinasa de ochrobactrum anthropi.
AU2001267172A1 (en) Novel n-substituted phenothiazines and their use as modulators of serine hydrolase enzymes
DE59805112D1 (de) Chimäre oligonucleotide und ihre verwendung
WO2003006610A3 (en) Thermostable phosphatases and methods of making and using them